Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

DGE Hosts the 5th Investigator-Initiated Trials Summit in Philadelphia 

The 5th Investigator-Initiated Trials Summit will take place in Philadelphia on November 13–14, 2025.  As the premier gathering for life sciences professionals driving IIT programs, this event unites clinical leaders, researchers, and industry experts to dissect common challenges happening in the IIT space.  Investigator-initiated research continues to serve as a cornerstone of clinical innovation, creating […]

GlobalTech Corp. (GLTK) Weaves a Portfolio of AI-Powered Solutions That Are Revolutionizing Industries Like Sports, E-commerce, Education and Others

GlobalTech (OTC: GLTK) is a technology holding company that specializes in industries like AI, big data, and digital infrastructure. The company continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances. GLTK has a strong portfolio of products and acquisitions in a variety of industries like digital lending, compliance, retail, sports, recruitment, and […]

Oncotelic Therapeutics Inc. (OTLC) Venture Sapu Nano Receives Approval to Begin Human Clinical Trials of Sapu003, an Injectible Form of Afinitor(R) (Everolimus) for Breast Cancer Treatment

Sapu Nano, part of a group of companies formed through GMP Biotechnology Limited, which is a joint venture between Oncotelic Therapeutics (OTCQB: OTLC) and Dragon Overseas Capital Limited, recently received approval from the HREC in Australia to begin enrolling people in clinical trails of Sapu003 for the treatment of breast cancer. Sapu003 is an injectible […]

SuperCom Ltd. (NASDAQ: SPCB) Expands European Presence with New $7 Million German Contract, Covering Multiple Programs

SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, has been awarded a national electronic monitoring (“EM”) contract in Germany, marking a strategic expansion into Europe’s largest economy. The program budget is estimated at $7 million over four years, with actual revenues depending on usage levels, according to a company news […]

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development

Hoth Therapeutics (NASDAQ: HOTH), a biopharmaceutical company, recently announced that the company is using an AI-powered platform developed by Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotech company and pharma, to streamline and improve the drug development process (https://ibn.fm/VIL67). The platform, called PredictBBB.ai(TM), is a next-gen AI tool that was designed to help determine whether a […]

SuperCom Ltd. (NASDAQ: SPCB) Expands U.S. Footprint with New Wisconsin Project, 12th State in One Year

SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, has expanded into its 12th U.S. state through a new electronic monitoring (“EM”) project in Wisconsin. The company announced on September 17 that, in partnership with a Midwest service provider, it will deploy its PureSecurity(TM) EM technology for a sheriff’s department program […]

FDA Guidance Sets Lantern Pharma Inc. (NASDAQ: LTRN) On a Path Toward Realizing Its Clinical Trial Plans for Rare Pediatric Cancer Therapy

Clinical-stage cancer technology company Lantern Pharma (NASDAQ: LTRN) is preparing for the launch of a trial targeting a rare pediatric disease, planned for Q1 2026, in the wake of the company’s optimistic meeting with the U.S. Food and Drug Administration (“FDA”) to receive critical guidance on the company’s trial design and the FDA’s regulatory pathway. […]

West Vault Mining Inc. (TSX.V: WVM) (OTCQX: WVMDF) Poised to Unlock Value Through Strong Gold Market Fundamentals

Maximizing Gold Leverage While Minimizing Risk Gold has surged to new record highs – recently surpassing $3,780 per ounce – as investors worldwide turn to the metal’s proven role as a hedge against inflation, currency weakness, and financial-market volatility (ibn.fm/29CUk). With expectations of rate cuts, central bank demand, and softer global growth, analysts see further […]

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ): Positioned at the Center of U.S. Copper Security and Policy

The convergence of market demand, national security priorities, and federal policy is reshaping the U.S. copper landscape. Copper, essential for defense systems, infrastructure, and emerging technologies, has become a focal point of strategic concern. The combination of executive action and critical minerals policy highlights the urgent need to secure domestic sources, a development that positions […]

Strawberry Fields REIT Inc.’s (NYSE AMERICAN: STRW) CEO, Moishe Gubin, Reflects on the Company’s Milestones on Bell2Bell Podcast

Strawberry Fields REIT (NYSE: AMERICAN: STRW), a self-administered real estate investment trust engaged in the ownership, acquisition, and leasing of skilled nursing and specific other healthcare-related properties, is celebrating 10 years of operation. While appearing on The Bell2Bell Podcast, CEO Moishe Gubin reflected on the company’s success, the milestones it has achieved, and where the […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

March 20, 2026

Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and unmet medical needs, recently received such recognition as its […]

Rotate your device 90° to view site.